Parkinson’s Disease Biochemistry, Clinical Pathology, and Treatment
Parkinson's disease is one of the major causes of neurological disability in adult life. It has been encountered in all races, in every region of the world and shows no preference for either sex. In general, its initial manifestations begin in the fifth decade of life. With the world population...
| Main Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Vienna
Springer Vienna
1983, 1983
|
| Edition: | 1st ed. 1983 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Generic and Trade Names
- Biochemistry
- General Principles of Biochemical Transmission
- Biochemical Changes in Parkinson’s Disease
- The Clinical Pathology of Parkinson’s Disease
- Tremor
- Rigidity
- Akinesia
- Various Terms
- Assessment of Parkinsonian Disability
- Autonomic Dysfunction
- Psychiatric Disturbances
- Pharmacotoxic Psychosis
- Treatment
- Anticholinergic Drug Therapy
- L-Dopa Treatment
- Combination Treatment with L-Dopa and a Decarboxylase Inhibitor
- Treatment with Tetrahydrobiopterin
- Amantadine
- Combined Treatment with MAO Inhibitors
- Deprenyl
- Tranylcypromine
- Dopamine Agonists
- Influence of Bromocriptine and Lisuride on Plasma Catecholamines and Urinary Metabolites
- Domperidone
- MIF
- ß-Blockers
- Treatment of Autonomic Symptoms
- Treatment of Psychiatric Symptoms
- The Drug Treatment of Parkinson’s Disease in Practice
- Drug Prescription Guide
- Neurosurgery
- Physiotherapy
- Side Effects
- Clinical Course of Parkinson’s Disease
- Observations on Human Behaviour
- References